New drugs, strategies and research designs for advanced non-small cell lung cancer
Hot topicsChairs: O. Burghuber (Vienna, Austria), G. Hardavella (London, United Kingdom)
Aims: This joint hot topic session with the EORTC offers a comprehensive overview of the latest developments in the treatment of advanced lung cancer. Current treatment strategies will be described. This will help attendees to integrate the newest clinical trial knowledge into routine lung cancer care. A perspective on new lung cancer study designs will also be provided.